Literature DB >> 19774328

Reduction in ECG abnormalities and improvement of regional left ventricular function in a patient with Fabry's disease during enzyme-replacement therapy.

Christian Prinz, Martin Farr, Detlef Hering, Dieter Horstkotte, Lothar Faber.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19774328     DOI： 10.1007/s00392-009-0084-3

Source DB:  PubMed          Journal:  Clin Res Cardiol        ISSN： 1861-0684            Impact factor:   5.460


× No keyword cloud information.
  3 in total

1.  Improvement of cardiac function during enzyme replacement therapy in patients with Fabry disease: a prospective strain rate imaging study.

Authors:  Frank Weidemann; Frank Breunig; Meinrad Beer; Joern Sandstede; Oliver Turschner; Wolfram Voelker; Georg Ertl; Anita Knoll; Christoph Wanner; Jörg M Strotmann
Journal:  Circulation       Date:  2003-09-02       Impact factor: 29.690

2.  Safety and efficacy of recombinant human alpha-galactosidase A replacement therapy in Fabry's disease.

Authors:  C M Eng; N Guffon; W R Wilcox; D P Germain; P Lee; S Waldek; L Caplan; G E Linthorst; R J Desnick
Journal:  N Engl J Med       Date:  2001-07-05       Impact factor: 91.245

Review 3.  Use of tissue Doppler imaging to identify and manage systemic diseases.

Authors:  Frank Weidemann; Joerg M Strotmann
Journal:  Clin Res Cardiol       Date:  2007-08-29       Impact factor: 5.460
  3 in total
  4 in total

1.  Value of the CHA2DS2-VASc score and Fabry-specific score for predicting new-onset or recurrent stroke/TIA in Fabry disease patients without atrial fibrillation.

Authors:  Dan Liu; Kai Hu; Marie Schmidt; Jonas Müntze; Octavian Maniuc; Daniel Gensler; Daniel Oder; Tim Salinger; Frank Weidemann; Georg Ertl; Stefan Frantz; Christoph Wanner; Peter Nordbeck
Journal:  Clin Res Cardiol       Date:  2018-05-24       Impact factor: 5.460

2.  Progression of electrocardiogram changes in an untreated fabry disease: a case report.

Authors:  Isabel Mattig; Sima Canaan-Kühl; Christoph Tillmanns; Fabian Knebel
Journal:  Eur Heart J Case Rep       Date:  2021-02-20

3.  Green tea halts progression of cardiac transthyretin amyloidosis: an observational report.

Authors:  Arnt V Kristen; Stephanie Lehrke; Sebastian Buss; Derliz Mereles; Henning Steen; Philipp Ehlermann; Stefan Hardt; Evangelos Giannitsis; Rupert Schreiner; Uwe Haberkorn; Philipp A Schnabel; Reinhold P Linke; Christoph Röcken; Erich E Wanker; Thomas J Dengler; Klaus Altland; Hugo A Katus
Journal:  Clin Res Cardiol       Date:  2012-05-15       Impact factor: 5.460

Review 4.  Deciphering hypertrophic cardiomyopathy with electrocardiography.

Authors:  Thomas Gossios; Konstantinos Savvatis; Thomas Zegkos; Dimitrios Ntelios; Pavlos Rouskas; Despoina Parcharidou; Haralambos Karvounis; Georgios K Efthimiadis
Journal:  Heart Fail Rev       Date:  2021-07-21       Impact factor: 4.654
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.